PATENTS

VASOINHIBIN BINDING MONOCLONAL ANTIBODY OR VASOINHIBIN BINDING FRAGMENT THEREOF

PCT/EP2024/073698 | WO/2025/098661 | EP24758280

In plain terms: this patent covers a laboratory-made (monoclonal) antibody that specifically recognizes and binds vasoinhibin — a protein fragment that helps regulate the growth and function of blood vessels. Because the antibody attaches only to vasoinhibin, it can be used to detect and measure this molecule reliably, providing a basis for diagnostic tests and potential therapies.

OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION

PCT/EP2020/069154 | WO/2021/098996 | EP4061394

In plain terms: this patent describes a short, synthetic protein fragment (an oligopeptide) that can slow the formation of new blood vessels. Being able to control blood-vessel growth in this targeted way is of interest for diseases in which abnormal or excessive vessel formation plays a role, such as certain eye conditions and tumors.